These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19369578)

  • 21. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
    Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
    Naitoh T; Kitahara M; Tsuruzoe N
    Cell Biol Toxicol; 2000; 16(2):131-5. PubMed ID: 10917568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.
    Cho DH; Lee EJ; Kwon KJ; Shin CY; Song KH; Park JH; Jo I; Han SH
    J Neurochem; 2013 Sep; 126(5):685-95. PubMed ID: 23581463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
    Aoun P; Simpkins JW; Agarwal N
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.
    Gras D; Chanez P; Urbach V; Vachier I; Godard P; Bonnans C
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L970-8. PubMed ID: 19346435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
    Asakawa M; Takano H; Nagai T; Uozumi H; Hasegawa H; Kubota N; Saito T; Masuda Y; Kadowaki T; Komuro I
    Circulation; 2002 Mar; 105(10):1240-6. PubMed ID: 11889020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes.
    Davies GF; McFie PJ; Khandelwal RL; Roesler WJ
    J Pharmacol Exp Ther; 2002 Jan; 300(1):72-7. PubMed ID: 11752099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery.
    Rusinova R; Herold KF; Sanford RL; Greathouse DV; Hemmings HC; Andersen OS
    J Gen Physiol; 2011 Aug; 138(2):249-70. PubMed ID: 21788612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
    Skolnik PR; Rabbi MF; Mathys JM; Greenberg AS
    J Acquir Immune Defic Syndr; 2002 Sep; 31(1):1-10. PubMed ID: 12352144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.
    Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD
    J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells.
    Okura T; Nakamura M; Takata Y; Watanabe S; Kitami Y; Hiwada K
    Eur J Pharmacol; 2000 Nov; 407(3):227-35. PubMed ID: 11068018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
    Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
    Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion.
    Lew JL; Zhao A; Yu J; Huang L; De Pedro N; Peláez F; Wright SD; Cui J
    J Biol Chem; 2004 Mar; 279(10):8856-61. PubMed ID: 14684751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
    Wang M; Wise SC; Leff T; Su TZ
    Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.
    de Dios ST; Hannan KM; Dilley RJ; Hill MA; Little PJ
    J Diabetes Complications; 2001; 15(3):120-7. PubMed ID: 11358680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance and its treatment by thiazolidinediones.
    Lebovitz HE; Banerji MA
    Recent Prog Horm Res; 2001; 56():265-94. PubMed ID: 11237217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor.
    Xu X; Xu X; Liu P; Zhu ZY; Chen J; Fu HA; Chen LL; Hu LH; Shen X
    J Biol Chem; 2015 Aug; 290(32):19888-99. PubMed ID: 26100621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
    Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
    J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.